These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27382035)

  • 21. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
    Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
    Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
    J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver.
    Preuss C; Jelenik T; Bódis K; Müssig K; Burkart V; Szendroedi J; Roden M; Markgraf DF
    Cells; 2019 Mar; 8(3):. PubMed ID: 30909521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceramides in Metabolism: Key Lipotoxic Players.
    Chaurasia B; Summers SA
    Annu Rev Physiol; 2021 Feb; 83():303-330. PubMed ID: 33158378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramuscular lipid metabolism, insulin action, and obesity.
    Consitt LA; Bell JA; Houmard JA
    IUBMB Life; 2009 Jan; 61(1):47-55. PubMed ID: 18839419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
    Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
    Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CerS1-Derived C
    Turpin-Nolan SM; Hammerschmidt P; Chen W; Jais A; Timper K; Awazawa M; Brodesser S; Brüning JC
    Cell Rep; 2019 Jan; 26(1):1-10.e7. PubMed ID: 30605666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
    Smith AG; Muscat GE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceramide analog C2-cer induces a loss in insulin sensitivity in muscle cells through the salvage/recycling pathway.
    Bandet CL; Tan-Chen S; Ali-Berrada S; Campana M; Poirier M; Blachnio-Zabielska A; Pais-de-Barros JP; Rouch C; Ferré P; Foufelle F; Le Stunff H; Hajduch E
    J Biol Chem; 2023 Jun; 299(6):104815. PubMed ID: 37178918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Exercise Training on Skeletal Muscle Insulin Resistance in Aging: Spotlight on Muscle Ceramides.
    Reidy PT; Mahmassani ZS; McKenzie AI; Petrocelli JJ; Summers SA; Drummond MJ
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098447
    [No Abstract]   [Full Text] [Related]  

  • 31. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
    Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ
    J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans.
    Bergman BC; Brozinick JT; Strauss A; Bacon S; Kerege A; Bui HH; Sanders P; Siddall P; Kuo MS; Perreault L
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E398-408. PubMed ID: 26126684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceramide content is higher in type I compared to type II fibers in obesity and type 2 diabetes mellitus.
    Kristensen D; Prats C; Larsen S; Ara I; Dela F; Helge JW
    Acta Diabetol; 2013 Oct; 50(5):705-12. PubMed ID: 22350135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial electron transport chain, ceramide, and coenzyme Q are linked in a pathway that drives insulin resistance in skeletal muscle.
    Diaz-Vegas A; Madsen S; Cooke KC; Carroll L; Khor JXY; Turner N; Lim XY; Astore MA; Morris JC; Don AS; Garfield A; Zarini S; Zemski Berry KA; Ryan AP; Bergman BC; Brozinick JT; James DE; Burchfield JG
    Elife; 2023 Dec; 12():. PubMed ID: 38149844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New role for ceramide in hypoxia and insulin resistance.
    Xia QS; Lu FE; Wu F; Huang ZY; Dong H; Xu LJ; Gong J
    World J Gastroenterol; 2020 May; 26(18):2177-2186. PubMed ID: 32476784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
    Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
    Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?
    Brøns C; Grunnet LG
    Eur J Endocrinol; 2017 Feb; 176(2):R67-R78. PubMed ID: 27913612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The path to insulin resistance: paved with ceramides?
    Zierath JR
    Cell Metab; 2007 Mar; 5(3):161-3. PubMed ID: 17339023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
    Babenko NA; Kharchenko VS
    Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Messengers: ceramides.
    Summers SA; Chaurasia B; Holland WL
    Nat Metab; 2019 Nov; 1(11):1051-1058. PubMed ID: 32694860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.